This is an early access version
Department of Gastroenterology and Hepatology, University Clinical Centre of the Republic of Srpska , Banja Luka , Bosnia and Herzegovina
Faculty of Medicine Foča, University of East Sarajevo , Foča , Bosnia and Herzegovina
Faculty of Medicine, University of Banja Luka , Banja Luka , Bosnia and Herzegovina
Department of Gastroenterology and Hepatology, University Clinical Centre of the Republic of Srpska , Banja Luka , Bosnia and Herzegovina
Faculty of Medicine, University of Banja Luka , Banja Luka , Bosnia and Herzegovina
Metformin (dimethyl biguanide) is an oral antidiabetic agent and one of the most commonly prescribed medications in endocrinology. In addition to its primary use in treating type 2 diabetes, it has a broader range of indications and is generally considered to have a favorable safety profile. The most common side effects are gastrointestinal, including nausea, vomiting, diarrhea, abdominal pain, and bloating. Although rare, cases of severe liver injury attributed to metformin have been reported. This paper provides a review of the existing literature on metformin-induced hepatotoxicity.
Conceptualization, G.B.; Data curation, G.B.; Funding acquisition, G.B.; Investigation, G.B.; Methodology, G.B.; Resources, G.B.; Software, G.B.; Visualization, G.B.; Writing – original draft, G.B.; Writing – review & editing, G.B.; Formal Analysis, Z.M.; Supervision, Z.M.; Validation, Z.M. All authors have read and agreed to the published version of the manuscript.
Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. 
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.